Literature DB >> 19468734

Vaccination against atherosclerosis? Induction of atheroprotective immunity.

Göran K Hansson1, Jan Nilsson.   

Abstract

Atherosclerosis involves the formation of inflammatory arterial lesions and is one of the most common causes of death globally. It has been evident for more than 20 years that adaptive immunity regulates the magnitude of the atherogenic proinflammatory response. T cells may also influence the stability of the atherosclerotic lesion and thus the propensity for thrombus formation and the clinical outcome of disease. Immunization of hypercholesterolemic animals with low-density lipoprotein preparations reduces atherosclerosis, suggesting that vaccination may represent a useful strategy for disease prevention or modulation. This review summarizes our current understanding of the role immunity in atherosclerosis and outlines strategies for antigen-specific prevention of this disease.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19468734     DOI: 10.1007/s00281-009-0151-x

Source DB:  PubMed          Journal:  Semin Immunopathol        ISSN: 1863-2297            Impact factor:   9.623


  55 in total

Review 1.  Scavenger receptors in innate immunity.

Authors:  Leanne Peiser; Subhankar Mukhopadhyay; Siamon Gordon
Journal:  Curr Opin Immunol       Date:  2002-02       Impact factor: 7.486

2.  Phosphorylcholine-targeting immunization reduces atherosclerosis.

Authors:  Giuseppina Caligiuri; Jamila Khallou-Laschet; Marta Vandaele; Anh-Thu Gaston; Sandrine Delignat; Chantal Mandet; Heinz V Kohler; Srini V Kaveri; Antonino Nicoletti
Journal:  J Am Coll Cardiol       Date:  2007-07-23       Impact factor: 24.094

3.  The effects of total lymphocyte deficiency on the extent of atherosclerosis in apolipoprotein E-/- mice.

Authors:  A Daugherty; E Puré; D Delfel-Butteiger; S Chen; J Leferovich; S E Roselaar; D J Rader
Journal:  J Clin Invest       Date:  1997-09-15       Impact factor: 14.808

Review 4.  The immune response in atherosclerosis: a double-edged sword.

Authors:  Göran K Hansson; Peter Libby
Journal:  Nat Rev Immunol       Date:  2006-06-16       Impact factor: 53.106

5.  Detection of activated T lymphocytes in the human atherosclerotic plaque.

Authors:  G K Hansson; J Holm; L Jonasson
Journal:  Am J Pathol       Date:  1989-07       Impact factor: 4.307

6.  LDL immunization induces T-cell-dependent antibody formation and protection against atherosclerosis.

Authors:  X Zhou; G Caligiuri; A Hamsten; A K Lefvert; G K Hansson
Journal:  Arterioscler Thromb Vasc Biol       Date:  2001-01       Impact factor: 8.311

7.  T and B lymphocytes play a minor role in atherosclerotic plaque formation in the apolipoprotein E-deficient mouse.

Authors:  H M Dansky; S A Charlton; M M Harper; J D Smith
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-29       Impact factor: 11.205

8.  Inhibition of atherosclerosis in apoE-null mice by immunization with apoB-100 peptide sequences.

Authors:  Gunilla Nordin Fredrikson; Ingrid Söderberg; Marie Lindholm; Paul Dimayuga; Kuang-Yuh Chyu; Prediman K Shah; Jan Nilsson
Journal:  Arterioscler Thromb Vasc Biol       Date:  2003-03-20       Impact factor: 8.311

9.  Toll-like receptor 4 polymorphisms and atherogenesis.

Authors:  Stefan Kiechl; Eva Lorenz; Markus Reindl; Christian J Wiedermann; Friedrich Oberhollenzer; Enzo Bonora; Johann Willeit; David A Schwartz
Journal:  N Engl J Med       Date:  2002-07-18       Impact factor: 91.245

10.  Lymphotoxin beta receptor signaling promotes tertiary lymphoid organogenesis in the aorta adventitia of aged ApoE-/- mice.

Authors:  Rolf Gräbner; Katharina Lötzer; Sandra Döpping; Markus Hildner; Dörte Radke; Michael Beer; Rainer Spanbroek; Beatrix Lippert; Catherine A Reardon; Godfrey S Getz; Yang-Xin Fu; Thomas Hehlgans; Reina E Mebius; Michael van der Wall; Dagmar Kruspe; Christoph Englert; Agnes Lovas; Desheng Hu; Gwendalyn J Randolph; Falk Weih; Andreas J R Habenicht
Journal:  J Exp Med       Date:  2009-01-12       Impact factor: 14.307

View more
  29 in total

Review 1.  Atherosclerosis and the role of immune cells.

Authors:  Fulya Ilhan; Sevgi Tas Kalkanli
Journal:  World J Clin Cases       Date:  2015-04-16       Impact factor: 1.337

Review 2.  Inflammation in atherosclerosis.

Authors:  Peter Libby
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-09       Impact factor: 8.311

Review 3.  Adaptive immunity in atherogenesis: new insights and therapeutic approaches.

Authors:  Andrew H Lichtman; Christoph J Binder; Sotirios Tsimikas; Joseph L Witztum
Journal:  J Clin Invest       Date:  2013-01-02       Impact factor: 14.808

Review 4.  Regulatory T cells in atherosclerosis: critical immune regulatory function and therapeutic potential.

Authors:  Charlotte Spitz; Holger Winkels; Christina Bürger; Christian Weber; Esther Lutgens; Göran K Hansson; Norbert Gerdes
Journal:  Cell Mol Life Sci       Date:  2015-10-30       Impact factor: 9.261

5.  Atheroprotective immunization with malondialdehyde-modified LDL is hapten specific and dependent on advanced MDA adducts: implications for development of an atheroprotective vaccine.

Authors:  Ayelet Gonen; Lotte F Hansen; William W Turner; Erica N Montano; Xuchu Que; Apaїs Rafia; Meng-Yun Chou; Philipp Wiesner; Dimitrios Tsiantoulas; Maripat Corr; Michael S VanNieuwenhze; Sotirios Tsimikas; Christoph J Binder; Joseph L Witztum; Karsten Hartvigsen
Journal:  J Lipid Res       Date:  2014-08-20       Impact factor: 5.922

Review 6.  Beyond vascular inflammation--recent advances in understanding atherosclerosis.

Authors:  Dennis Wolf; Andreas Zirlik; Klaus Ley
Journal:  Cell Mol Life Sci       Date:  2015-06-23       Impact factor: 9.261

7.  Treg-mediated suppression of atherosclerosis requires MYD88 signaling in DCs.

Authors:  Manikandan Subramanian; Edward Thorp; Goran K Hansson; Ira Tabas
Journal:  J Clin Invest       Date:  2012-12-21       Impact factor: 14.808

8.  Safety and efficacy trial of adipose-tissue derived oral preparation V-6 Immunitor (V-6): results of open-label, two-month, follow-up study.

Authors:  Aldar S Bourinbaiar; Vichai Jirathitikal
Journal:  Lipids Health Dis       Date:  2010-02-02       Impact factor: 3.876

9.  Engineering nanomaterials to address cell-mediated inflammation in atherosclerosis.

Authors:  Sean Allen; Yu-Gang Liu; Evan Scott
Journal:  Regen Eng Transl Med       Date:  2016-03-03

Review 10.  Dendritic cells in atherosclerosis.

Authors:  Manikandan Subramanian; Ira Tabas
Journal:  Semin Immunopathol       Date:  2013-11-06       Impact factor: 9.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.